Literature DB >> 25694802

Implant surgery and oral anticoagulant therapy: case report.

M Miranda1, P Bollero2, N D'Ovidio1, V Marsango1, A Barlattani1.   

Abstract

OBJECTIVES: This work aims to assess the risks both thromboembolic that bleeding of a management protocol "non-conservative" in patients on oral anticoagulant therapy (OAT) to be undergoing implant surgery.
MATERIALS AND METHODS: We decided to take a surgical "non-conservative" protocol, to insert four implants in the aesthetic zone, without using flapless surgery and the surgical template. In accordance with the hematologist, the value of INR is lowered and warfarin was replaced with heparin low molecular weight, to have a better coagulation's control.
RESULTS: The modern guidelines impose a protocol of conservative management in patients with OAT, with minimally invasive surgery, flapless, and use of surgical template to reduce the risk of uncontrolled bleeding. This, thanks to the team-work between dentist and hematologist, thanks to careful adjustment of INR and the use of local haemostatic agents, were not encountered any problems with bleeding or intra or postoperative.
CONCLUSION: Surgical treatment of patients with OAT is a real problem for the oral surgeon, to treat every time in association with the hematologist. Applying this type of surgical procedure, different from today's guidelines, in our experience there were no post-operative complications (bleeding or bleeding); osseointegration has not been compromised and the prosthetic rehabilitation was completed successfully.

Entities:  

Keywords:  OAT; implant surgery; oral pathology; protocol “non conservative”

Year:  2014        PMID: 25694802      PMCID: PMC4302744     

Source DB:  PubMed          Journal:  Oral Implantol (Rome)        ISSN: 1974-5648


  25 in total

1.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.

Authors:  Mark A Crowther; Jeff S Ginsberg; Jim Julian; Judah Denburg; Jack Hirsh; James Douketis; Carl Laskin; Paul Fortin; David Anderson; Clive Kearon; Ann Clarke; William Geerts; Melissa Forgie; David Green; Lorrie Costantini; Wendy Yacura; Sarah Wilson; Michael Gent; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

2.  AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.

Authors:  J Acar; B Iung; J P Boissel; M M Samama; P L Michel; J P Teppe; J C Pony; H L Breton; D Thomas; R Isnard; G de Gevigney; E Viguier; A Sfihi; G Hanania; M Ghannem; A Mirode; C Nemoz
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

3.  Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation.

Authors:  Albert L Waldo; Richard C Becker; Victor F Tapson; Kevin J Colgan
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

4.  A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

Authors:  G Finazzi; R Marchioli; V Brancaccio; P Schinco; F Wisloff; J Musial; F Baudo; M Berrettini; S Testa; A D'Angelo; G Tognoni; T Barbui
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

Review 5.  What influence do anticoagulants have on oral implant therapy? A systematic review.

Authors:  Carlos Madrid; Mariano Sanz
Journal:  Clin Oral Implants Res       Date:  2009-09       Impact factor: 5.977

6.  A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.

Authors: 
Journal:  Ann Neurol       Date:  1997-12       Impact factor: 10.422

Review 7.  Perioperative management of patients receiving oral anticoagulants: a systematic review.

Authors:  Andrew S Dunn; Alexander G G Turpie
Journal:  Arch Intern Med       Date:  2003-04-28

Review 8.  Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Alan S Go; Jonathan L Halperin; Warren J Manning
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

Review 9.  Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Robert A Harrington; Richard C Becker; Michael Ezekowitz; Thomas W Meade; Christopher M O'Connor; David A Vorchheimer; Gordon H Guyatt
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

Review 10.  Pretreatment management of the patient receiving anticoagulant drugs.

Authors:  R Mulligan; K G Weitzel
Journal:  J Am Dent Assoc       Date:  1988-09       Impact factor: 3.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.